Pituitary & hypothalamus

Central diabetes insipidus (vasopressin deficiency) after surgery for pituitary tumours: a systematic review and meta-analysis

Eur J EndocrinolPublished Systematic review and meta-analysis

Authors' conclusion

Following TSS, a small proportion of patients with pituitary adenoma have permanent AVP-D (2%), but prevalence reaches 30% in ones with craniopharyngioma and 14% in those with RCC. Diagnostic criteria for post-operative AVP-D remain variable affecting reported rates of this condition.

Study context

Population
Patients with pituitary adenoma, craniopharyngioma or Rathke's cleft cyst (RCC) treated with transsphenoidal surgery (TSS); studies 2000–2021 providing a definition of post-operative AVP-D51 studies
Comparison
Pituitary adenoma vs Craniopharyngioma vs RCC
Outcome
Rates of newly developed transient or permanent AVP-D after TSS
Methodological detailsrandom effects meta-analysis, Freeman-Tukey transformation, Medline, Embase and Cochrane Library searched, January 1, 2000 to January 31, 2021; 51 of 11 694 studies included
  • Random effects meta-analysis
  • Freeman-Tukey transformation
  • Medline, Embase and Cochrane Library searched, January 1, 2000 to January 31, 2021; 51 of 11 694 studies included

Pooled result

As reported in the abstract

Transient / permanent AVP-D (pooled proportion)
Total: transient AVP-D
17% (95% CI, 13-21)
Total: permanent AVP-D
3% (95% CI, 2-5)
Pituitary adenoma: transient AVP-D
16% (95% CI, 12-21)
Pituitary adenoma: permanent AVP-D
2% (95% CI, 2-3)
Craniopharyngioma: transient AVP-D
31% (95% CI, 24-39)
Craniopharyngioma: permanent AVP-D
30% (95% CI, 22-39)
RCC: transient AVP-D
35% (95% CI, 16-57)
RCC: permanent AVP-D
14% (95% CI, 6-23)

Further pooled results

Transient / permanent AVP-D by diagnostic criteria

Hypotonic polyuria: transient AVP-D
14% (95% CI, 8-22)
Hypotonic polyuria: permanent AVP-D
3% (95% CI, 1-4)
Hypotonic polyuria and hypernatraemia: transient AVP-D
21% (95% CI, 13-29)
Hypotonic polyuria and hypernatraemia: permanent AVP-D
5% (95% CI, 2-11)
Desmopressin administration: transient AVP-D
22% (95% CI, 15-29)
Desmopressin administration: permanent AVP-D
9% (95% CI, 0-30)

Original publication

Central diabetes insipidus (vasopressin deficiency) after surgery for pituitary tumours: a systematic review and meta-analysis. Eur J Endocrinol. Published 12 July 2024. doi:10.1093/ejendo/lvae084

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.